(Am J Cardioi U myocardial metabolism in humans early after an abrupt occlusion of a major coronary artery has not been feasible. Percutaneous transluminal coronary angioplasty (PTCA), however, now provides a unique opportunity to study the time course of these metabolic changes during the transient interruption of coronary flow by the balloon occlusion sequence in patients with l-vessel disease and without angiographically demonstrable collateral circulation.1,2 The need to detect any persisting metabolic or mechanical dysfunction becomes of even greater concern as the number of dilated vessels and the duration of balloon inflation tend to increase, thereby enhancing both the extent and the severity of ischemia. The risk exists that the damage induced by the intervention may exceed its benefit.
During and after ischemia, there is in the heart, as well as in other muscles, excessive adenosine triphosphate (ATP) breakdown. This degradation of ATP causes an efflux of breakdown products, which are able to pass through the cell membrane into the blood before significant amounts of enzymes appear. The purine derivatives adenosine, inosine and hypoxanthine are therefore thought to be early markers for ischemia.3 Because of high activities of adenosine deaminase and low amounts of nucleoside phosphorylase and xanthine oxidase in the heart and blood, hypoxanthine seems most promising as an early marker for myocardial ischemia.4
Recently, high-pressure liquid chromatography (HPLC) came into use for the determination of nucleosides and purine bases in the whole blood,5,6 facilitating the determination of purine derivatives, in particular hypoxanthine. This new technical development prompted us to investigate the myocardial release of hypoxanthine during coronary angioplasty.
Patients: All patients met the following criteria: a brief history of angina pectoris (<l year), an isolated obstructive lesion in 1 coronary vessel (the left anterior descending artery) and an accessible stenosis of < 1 cm in length. All patients were candidates for coronary artery bypass graft surgery because of disabling angina, but were selected for angioplasty rather than surgery because of their anatomy.
Fifteen patients (12 men and 3 women, aged 38 to 74 years) were studied. Of these, 4 were in New York Heart Association class II, 9 in class III and 2 in class IV. In all, the ejection fraction was >50% and none of them had wall motion abnormalities on their diagnostic left ventriculograms at rest. Four transluminal dilatations were performed with a total duration of occlusion of 192 f 40 seconds (mean f standard deviation). All patients in the study underwent successful reperfusion with the 4 episodes of PTCA. All patients in this study gave their informed consent and there were no complications directly related to the research procedure.
Percutaneous transluminal coronary angioplasty:
PTCA was performed according to the technique of Gruentzig, with the equipment of Schneider, via the femoral route. In all cases the pressure gradient across the obstructive lesion was recorded before, during and after balloon inflation. The dilatation catheters were either the 20 to 30 or 20 to 37 models. The inflation pressure ranged from 2 to 12 atm, whereas the individual duration of occlusion ranged from 40 to 60 seconds. Coronary angiography with nonionic contrast medium (metrizamide) was performed before and at the end of the PTCA procedure. Premeditation consisted of aspirin, and all patients received 3 mg of isosorbide dinitrate selectively into the left main coronary artery during control coronary arteriography, but the coronary flow measurements we report were not performed within the periods of the drug's effect on the coronary circulation. Therapy with P-blocking drugs was not discontinued. During the procedure, heparin and low molecular weight dextran were administered intravenously.
Lactate and hypoxanthine determinations:
Blood samples were obtained from the great cardiac vein and the left coronary artery at 6 consecutive measurement periods: before the PTCA procedure, 5 to 10 seconds after each transluminal occlusion and 5 minutes after termination-of the PTCA procedure. Five minutes were allowed between each dilatation for recovery.
Blood (1.5 ml) for lactate measurements was rapidly deproteinized with an equal volume of cold 8% perchloric acid (HC104) and centrifuged. After centrifugation, the supernatant fluids were stored at -2O'C. Lactate in the supernatant was analyzed enzymatically 'according to Apstein et al7 with the AutoAnalyzer (Technicon, Tarrytown, New York). Standard curves were made with lithium lactate in 4% HC104
An isocratic HPLC system was used for the estimation of purine nucleosides and oxypurines in blood.6 Use was made of a reversed-phase column. Because nucleotides derived from erythrocytes affected the separation, these.compounds had to be removed. The method of Chatterjee et al was used8 with some minor differences. We applied 1.5 ml of the deproteinized, neutralized blood sample onto a prewashed column of A1203 (0.6 g) in a Pasteur pipette, and eluted it with 5.0 ml 10 mmol/liter Tris/HCl, pH 7.4. For faster elution, a vacuum was applied to a sampling manifold. Twelve samples were treated at the same time. A Waters M 6000 HPLC* was used with a WISP 710 B autosampler,* a model 440 UVdetector* fixed at 254 nm wavelength connected to a BD 41 recorder.7 A 4 mm I.D. X 30 cm prepacked p Bondapak/Cis column,* particle size 10 pm, was used,in these studies. Chromatographic conditions were adapted from earlier work9: 200 ~1 samples were eluted from this column with 10 mmol/liter NH,+Hz POd/CHsOH (lO:l, v/v), pH 5.50. The flow rate was 60 ml/hour (Fig. 1 ).
Flow and resistance measurements:
Great cardiac vein blood flow was measured by the continuous thermodilution method before and after the PTCA procedure as well as during each transluminal occlusion. In the beginning of the investigation the location of the external thermistor, in the great cardiac vein, was verified by injection of 3 ml of contrast material. Each recording of blood flow during coronary angioplasty began before balloon inflation and was interrupted at the moment of balloon deflation. Coronary vascular resistance (CVR) was calculated for great cardiac veinlo using the mean arterial pressure (MAP) and blood flow in the great cardiac vein: CVR = MAP/Flow (mm Hg/ml/min) Statistical analysis: Results are expressed as mean f standard error of the mean. Comparison between results before and after PTCA and occlusion conditions were evaluated using analysis of variance for repeated measurements. When overall significance was found, multi-*Millipore Waters, Bedford, Massachusetts. tKipp en Zonen, Delft, the Netherlands.
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ple comparisons were significantly different at the 0.05 level.
RESULTS

Coronary hemodynamic measurements:
The results of the coronary hemodynamic observations are summarized in Figure 2 and Table I . During the initial dilatation, the mean duration of balloon inflation was 44 f 4 seconds. During the subsequent dilatations the duration of inflation was slightly increased up to 49 f 6 seconds. Occlusion pressure did not change throughout these occlusion times of 40 to 60 seconds and there was a high degree of reproducibility of the occlusion pressure during these successive occlusions (Table I ). The mean blood flow in the great cardiac vein before the first inflation was 72 f 4 ml/min, decreasing to 47 f 10 ml/min (p <0.003) during the fourth inflation and increasing slightly to 93 f 8 ml/min (p <0.03) after completion of the PTCA procedure (Table I) before balloon inflation, 2.3 f 0.6 by the end of the fourth inflation (p <O.OOS) and 1.02 f 0.11 after completion of the PTCA procedure (Table I) .
Lactate aind hypoxanthine metabolism:
The arteriovenous lactate measurements are listed in Table I and shown in Figure 3 . The control measurements showed a difference of +O. 18 mM, which decreased to -1.1 and -0.91 mM, after the first and the second dilatations, respectively. After the third dilatation the lactate difference was -0.60 mM, which was not significantly different from the values recorded after the first and the second dilatation. As a first approximation, the, amount of lactate lost from the ischemic tissue during the 4 consecutive occlusions seems to be more or less constant and at least did not increase with the time. During the 4 consecutive transluminal occlusions, an average increase of hypoxanthine in the great cardiac vein, from 3.0 f 0.6 to 5.6 f 1.1 PM, (p <O.Ol) was observed, which fell off after completion of the PTCA procedure. The arterial levels of these compounds remained constant during transluminal occlusion. The myocardial arterial-great cardiac vein difference of hypoxanthine changed from 0.3 f 0.3 PM before angioplasty at rest to -2.4 f 1.2 PM (p <O.Ol) during sequential transluminal occlusions. Even if not statistically significant, a trend for hypoxanthine release to be reduced during occlusions 3 and 4 compared with occlusion 1 or 2 was observed. Significant production of hypoxanthine, calculated either as arteriovenous difference or extraction, only took place after the first 2 transluminal occlusions, whereas hypoxanthine release was absent 5 minutes after completion of the PTCA procedure.
DISCUSSION
Puiine versus lactate release as a marker for ischek mia during transluminal coronary occlusion in humans:
Ischemia can be defined as a situation in which coronary blood flow cannot meet the tissue demand." As a consequence of the ensuing oxygen deficiency, the balance between ATP production and usage is disturbed.12 ATP (and creatine phosphate) levels fa11,3J3 creatine, adenosine diphosphate (ADP), phosphate and hydrogen ion levels increase,14-l6 glycolysis rate is enhanced17J8 and lactate levels rise. Shortly thereafter, potassium ion, hydrogen ion and lactate are released into the coronary venous blood. ATP is converted to ADP and adenosine monophosphate (AMP), which is broken down to adenosine, inosine, hypoxanthine, xanthine and urate (Fig. 4) . The AMP catabolites pass the cell membrane.19-22 Thus, a slight decrease of ATP results in an immediate increase in AMP catabolites, and this release can be used to monitor myocardial ATP breakdown.
We believed, therefore, that measuring myocardial arteriovenous differences of blood hypoxanthine levels could give insight into the metabolic state of the heart4; 
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the method used here makes it possible to measure a normoxia, lactate is preferentially taken up by the number of AMP catabolites in blood. In fact, since the heart.28 In fact, lactate released from a local ischemic 196Os, several studies have discussed the release of purine area can be metabolized by the surrounding normoxic components during ischemia or anoxia.4,6,23-27 Lactate as tissue.17 The formation and removal of lactate is also a marker of ischemia, has several disadvantages. During influenced by blood fatty acid levels, acidosis and by hyperglycemia, 29 all metabolic conditions likely to be present during angioplasty.
Time of blood withdrawal and potential methodologic limitations:
In our patients, blood samples were obtained 5 to 10 seconds after the start of deflation. Coronary sinus potassium ion concentration has been measured continuously in patients undergoing angioplasty of significant stenoses of the left anterior descending coronary arteries.30 The recordings obtained from these patients showed that, although coronary sinus potassium ion levels did not change significantly during coronary occlusion, a transient increase occurred when the occlusion was removed. After reduction of the pressure in the balloon the coronary sinus potassium ion levels began to increase within 8 seconds. This fits approximately with the timing of peak reactive hyperemia observed by ourselves and by Rothman et a131 and corresponds with the timing of blood withdrawal in this study using a thermodilution technique.
More pronounced reactive hyperemia developed when the residual functional coronary stenosis associated with the deflated PTCA balloon was reduced by subsequent dilatation.'T31 In a previous study, we1 demonstrated that the mean hyperemic increase in great cardiac vein flow was 55% after the first dilatation and 91% after the third dilatation. We recently used an intracoronary Doppler velocity probe mounted on the angioplasty balloon catheter to analyze beat by beat the reactive hyperemic phase.32 This new methodologic approach made us more aware of the changing pattern of hyperemia, in terms of time course and extent, during repeated occlusion as part of the ongoing angioplasty procedure (Fig. 5) .
What was observed in this clinical setting probably differs from the (reproducible) reactive hyperemia observed in the experimental laboratory when transient occlusion of an otherwise healthy vessel (nonstenotic) is induced by an external snare or clamp. Since the left anterior descending artery flow was not recorded during the sampling period, results were not expressed in terms of lactate and hypoxanthine efflux. Therefore, the variation in lactate and hypoxanthine concentration in the great cardiac vein observed during the 4 sequential occlusions might have been considerably affected by dilutional phenomena related to the changing pattern of the reactive hyperemia. However, despite these methodologic limitations, it appears that the release of lactate and hypoxanthine from the ischemic tissue, during the last occlusions, does not increase with sequential occlusions. The fact that hypoxanthine washout drops off after the third inflation while lactate does not, could nevertheless be related to complex biochemical processes.
Dunn et a1,33 studied the temporal relation between reactive hyperemic blood flow, reduction in myocardial high-energy phosphate stores and removal of lactate in dogs. In the endocardium, where the greatest lactate changes occur during occlusion, the lactate level was still significantly above control after 30 seconds of reactive hyperemia when approximately three-fourths of the response had occurred. In contrast, a return of the highenergy phosphate stores to control level was already ap-SOE THE AMERICAN JOURNAL OF CARDIOLOGY VOLUME 63 parent at the time of the peak hyperemic flow when only one-fourth of the response had occurred. We speculate that different responses to ischemia of the glycolytic and purine pathways are responsible for the somewhat different lactate and hypoxanthine profiles observed (Fig. 3) . The great cardiac vein lactate and hypoxanthine returned to control levels at the end of the PTCA procedure. This indicates that the metabolic changes induced by PTCA are quickly reversible.
Metabolism after repetitive episodes of brief ischemia: Previous work34,35 indicates that repetitive episodes of brief ischemia do not produce a cumulative depletion of high-energy phosphate compounds. The content of nucleotide pools at any point in time is determined by the rate of synthesis vs demand. The failure to demonstrate a progressive decrease in nucleotide pools during subsequent ischemic episodes after an initial ischemic episode might be explained by a decreased degradation of nucleotides during the subsequent ischemic episodes. The mechanism for the putative decrease in coronary nucleotide degradation rate during subsequent episodes of ischemia is unclear, but several explanations have been proposed to account for this finding.36m39 There is growing evidence for compartmentation of myocardial nucleotide pool~.~~,~~ The different compartments in the cell may have different susceptibilities to depletion during myocardial ischemia. Susceptible pools may have been depleted during the first ischemic episode, with more resistant pools remaining intact during subsequent ischemic episodes of the same duration.
Besides these adaptive metabolic mechanisms, other hemodynamic factors have to be considered. Rentrop et a140 demonstrated the appearance of a previously absent coronary collateral circulation during balloon inflation. This apparent recruitment of collaterals might modulate metabolism during angioplasty although its functional significance is not yet well defined. The occlusion pressure measured distally to the stenosis, during balloon inflation, correlates well with the existence of collaterals demonstrable before or during angioplasty.41,42 However, Probst et a141 and Meier et a142 did not observe any change in coronary occlusion pressure during serial occlusions. The absence of any increase in coronary sinus and great cardiac vein flow during serial occlusions precludes the gradual recruitment of collateral circulation during repeated occlusions, which might have explained a possible change in lactate and hypoxanthine efflux.
CONCLUSION
The crucial conclusion to be drawn from our observations is that metabolic disturbances induced by repeated myocardial ischemia in humans are quickly reversible, provided they are of short durations (<90 seconds). 
